ZA200700104B - Biochemical synthesis of 1,4-butanediamine - Google Patents
Biochemical synthesis of 1,4-butanediamine Download PDFInfo
- Publication number
- ZA200700104B ZA200700104B ZA200700104A ZA200700104A ZA200700104B ZA 200700104 B ZA200700104 B ZA 200700104B ZA 200700104 A ZA200700104 A ZA 200700104A ZA 200700104 A ZA200700104 A ZA 200700104A ZA 200700104 B ZA200700104 B ZA 200700104B
- Authority
- ZA
- South Africa
- Prior art keywords
- encoding gene
- activity
- gene
- process according
- increased
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title claims description 70
- 238000003786 synthesis reaction Methods 0.000 title claims description 20
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 title description 81
- 230000000694 effects Effects 0.000 claims description 83
- 108090000623 proteins and genes Proteins 0.000 claims description 80
- 238000000034 method Methods 0.000 claims description 74
- 108700005126 Ornithine decarboxylases Proteins 0.000 claims description 61
- 102000052812 Ornithine decarboxylases Human genes 0.000 claims description 60
- 102000004190 Enzymes Human genes 0.000 claims description 54
- 108090000790 Enzymes Proteins 0.000 claims description 54
- 230000001965 increasing effect Effects 0.000 claims description 54
- 241000588724 Escherichia coli Species 0.000 claims description 53
- 230000008569 process Effects 0.000 claims description 51
- 239000013612 plasmid Substances 0.000 claims description 47
- YANFYYGANIYHGI-UHFFFAOYSA-N N-carbamoylputrescine Chemical compound NCCCCNC(N)=O YANFYYGANIYHGI-UHFFFAOYSA-N 0.000 claims description 36
- RFMMMVDNIPUKGG-YFKPBYRVSA-N N-acetyl-L-glutamic acid Chemical compound CC(=O)N[C@H](C(O)=O)CCC(O)=O RFMMMVDNIPUKGG-YFKPBYRVSA-N 0.000 claims description 34
- 108700024157 Agmatine deiminases Proteins 0.000 claims description 23
- 101000652415 Homo sapiens Agmatinase, mitochondrial Proteins 0.000 claims description 23
- 101000798222 Homo sapiens Antizyme inhibitor 2 Proteins 0.000 claims description 23
- 101000711499 Thermococcus kodakarensis (strain ATCC BAA-918 / JCM 12380 / KOD1) N(1)-aminopropylagmatine ureohydrolase Proteins 0.000 claims description 23
- 229960003104 ornithine Drugs 0.000 claims description 23
- 102100032252 Antizyme inhibitor 2 Human genes 0.000 claims description 22
- 102000011229 agmatinase Human genes 0.000 claims description 22
- 230000002018 overexpression Effects 0.000 claims description 21
- 108090000531 Amidohydrolases Proteins 0.000 claims description 20
- 244000005700 microbiome Species 0.000 claims description 20
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 18
- 102000004092 Amidohydrolases Human genes 0.000 claims description 16
- 241000894007 species Species 0.000 claims description 16
- 241001415395 Spea Species 0.000 claims description 15
- 108010032178 Amino-acid N-acetyltransferase Proteins 0.000 claims description 14
- 102000007610 Amino-acid N-acetyltransferase Human genes 0.000 claims description 14
- 229930195714 L-glutamate Natural products 0.000 claims description 14
- 101150029940 argJ gene Proteins 0.000 claims description 13
- 238000000855 fermentation Methods 0.000 claims description 13
- 230000004151 fermentation Effects 0.000 claims description 13
- 101150022778 speF gene Proteins 0.000 claims description 13
- 241000607142 Salmonella Species 0.000 claims description 12
- 101150072344 argA gene Proteins 0.000 claims description 12
- 101710202061 N-acetyltransferase Proteins 0.000 claims description 11
- 108090000489 Carboxy-Lyases Proteins 0.000 claims description 10
- 102000004031 Carboxy-Lyases Human genes 0.000 claims description 9
- 101150101115 speB gene Proteins 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 239000013598 vector Substances 0.000 claims description 8
- 241000186226 Corynebacterium glutamicum Species 0.000 claims description 7
- 241000588722 Escherichia Species 0.000 claims description 7
- 241000607768 Shigella Species 0.000 claims description 7
- 101150047781 ptcA gene Proteins 0.000 claims description 7
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 6
- 102100021079 Ornithine decarboxylase Human genes 0.000 claims description 6
- 108010055012 Orotidine-5'-phosphate decarboxylase Proteins 0.000 claims description 6
- 241001148062 Photorhabdus Species 0.000 claims description 6
- 241001138501 Salmonella enterica Species 0.000 claims description 6
- 241000607734 Yersinia <bacteria> Species 0.000 claims description 6
- 241000607479 Yersinia pestis Species 0.000 claims description 6
- 241000186249 Corynebacterium sp. Species 0.000 claims description 5
- 241000488157 Escherichia sp. Species 0.000 claims description 5
- 241000589516 Pseudomonas Species 0.000 claims description 5
- 241000187747 Streptomyces Species 0.000 claims description 5
- 241000193755 Bacillus cereus Species 0.000 claims description 4
- 241000186000 Bifidobacterium Species 0.000 claims description 4
- 241000588653 Neisseria Species 0.000 claims description 4
- 241000588650 Neisseria meningitidis Species 0.000 claims description 4
- 241001223867 Shewanella oneidensis Species 0.000 claims description 4
- 241000607762 Shigella flexneri Species 0.000 claims description 4
- 241000191940 Staphylococcus Species 0.000 claims description 4
- 241000219195 Arabidopsis thaliana Species 0.000 claims description 3
- QYPPJABKJHAVHS-UHFFFAOYSA-N Agmatine Natural products NCCCCNC(N)=N QYPPJABKJHAVHS-UHFFFAOYSA-N 0.000 claims description 2
- 241000219194 Arabidopsis Species 0.000 claims description 2
- 241000589151 Azotobacter Species 0.000 claims description 2
- 241000589149 Azotobacter vinelandii Species 0.000 claims description 2
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 claims description 2
- 241001453698 Buchnera <proteobacteria> Species 0.000 claims description 2
- 241000894010 Buchnera aphidicola Species 0.000 claims description 2
- 241000186216 Corynebacterium Species 0.000 claims description 2
- 241000186660 Lactobacillus Species 0.000 claims description 2
- 241001147746 Lactobacillus delbrueckii subsp. lactis Species 0.000 claims description 2
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 2
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 2
- 241000186781 Listeria Species 0.000 claims description 2
- 241000186779 Listeria monocytogenes Species 0.000 claims description 2
- 241000186359 Mycobacterium Species 0.000 claims description 2
- 241000186362 Mycobacterium leprae Species 0.000 claims description 2
- 241000383839 Novosphingobium Species 0.000 claims description 2
- 241000233540 Novosphingobium aromaticivorans Species 0.000 claims description 2
- 241001072230 Oceanobacillus Species 0.000 claims description 2
- 241001072247 Oceanobacillus iheyensis Species 0.000 claims description 2
- 241000606860 Pasteurella Species 0.000 claims description 2
- 241000606856 Pasteurella multocida Species 0.000 claims description 2
- 241001148064 Photorhabdus luminescens Species 0.000 claims description 2
- 241000235061 Pichia sp. Species 0.000 claims description 2
- 241000588769 Proteus <enterobacteria> Species 0.000 claims description 2
- 241000588770 Proteus mirabilis Species 0.000 claims description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 2
- 241000235088 Saccharomyces sp. Species 0.000 claims description 2
- 241000863430 Shewanella Species 0.000 claims description 2
- 241000194017 Streptococcus Species 0.000 claims description 2
- 241000194019 Streptococcus mutans Species 0.000 claims description 2
- 241001468227 Streptomyces avermitilis Species 0.000 claims description 2
- 241001647802 Thermobifida Species 0.000 claims description 2
- 241000203780 Thermobifida fusca Species 0.000 claims description 2
- 241000607598 Vibrio Species 0.000 claims description 2
- 241000607626 Vibrio cholerae Species 0.000 claims description 2
- QYPPJABKJHAVHS-UHFFFAOYSA-P agmatinium(2+) Chemical compound NC(=[NH2+])NCCCC[NH3+] QYPPJABKJHAVHS-UHFFFAOYSA-P 0.000 claims description 2
- 210000002615 epidermis Anatomy 0.000 claims description 2
- 229940039696 lactobacillus Drugs 0.000 claims description 2
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 2
- 229940051027 pasteurella multocida Drugs 0.000 claims description 2
- 229940118696 vibrio cholerae Drugs 0.000 claims description 2
- 210000004027 cell Anatomy 0.000 description 48
- 238000004519 manufacturing process Methods 0.000 description 41
- 238000005755 formation reaction Methods 0.000 description 36
- 239000012634 fragment Substances 0.000 description 22
- 230000035772 mutation Effects 0.000 description 17
- 238000010276 construction Methods 0.000 description 16
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 15
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 15
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 15
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 15
- 101150044368 speC gene Proteins 0.000 description 15
- 108020004414 DNA Proteins 0.000 description 14
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 14
- 238000004458 analytical method Methods 0.000 description 13
- 239000002609 medium Substances 0.000 description 13
- 239000013604 expression vector Substances 0.000 description 12
- 229920000768 polyamine Polymers 0.000 description 12
- 238000002360 preparation method Methods 0.000 description 12
- 239000006142 Luria-Bertani Agar Substances 0.000 description 11
- 229960000723 ampicillin Drugs 0.000 description 11
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 11
- 230000009466 transformation Effects 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 10
- 238000012261 overproduction Methods 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 108091034117 Oligonucleotide Proteins 0.000 description 9
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 9
- 238000012163 sequencing technique Methods 0.000 description 9
- 238000012795 verification Methods 0.000 description 9
- 239000004475 Arginine Substances 0.000 description 8
- 108090000794 Streptopain Proteins 0.000 description 8
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 8
- 239000013611 chromosomal DNA Substances 0.000 description 8
- 230000014509 gene expression Effects 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- 235000014469 Bacillus subtilis Nutrition 0.000 description 7
- 108020004705 Codon Proteins 0.000 description 7
- 239000002773 nucleotide Substances 0.000 description 7
- 125000003729 nucleotide group Chemical group 0.000 description 7
- 229930195712 glutamate Natural products 0.000 description 6
- 230000001939 inductive effect Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 229940063673 spermidine Drugs 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 108010042407 Endonucleases Proteins 0.000 description 5
- 102000004533 Endonucleases Human genes 0.000 description 5
- JRLGPAXAGHMNOL-LURJTMIESA-N N(2)-acetyl-L-ornithine Chemical compound CC(=O)N[C@H](C([O-])=O)CCC[NH3+] JRLGPAXAGHMNOL-LURJTMIESA-N 0.000 description 5
- 238000010367 cloning Methods 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 108091008146 restriction endonucleases Proteins 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 239000011550 stock solution Substances 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 239000005700 Putrescine Substances 0.000 description 4
- 230000003851 biochemical process Effects 0.000 description 4
- 230000036983 biotransformation Effects 0.000 description 4
- VHRGRCVQAFMJIZ-UHFFFAOYSA-N cadaverine Chemical compound NCCCCCN VHRGRCVQAFMJIZ-UHFFFAOYSA-N 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 238000006114 decarboxylation reaction Methods 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 238000011081 inoculation Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 230000036962 time dependent Effects 0.000 description 4
- 108700016258 Agmatinases Proteins 0.000 description 3
- 108700016156 Arginine decarboxylases Proteins 0.000 description 3
- 244000063299 Bacillus subtilis Species 0.000 description 3
- 241000276408 Bacillus subtilis subsp. subtilis str. 168 Species 0.000 description 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- 101150084989 Speg gene Proteins 0.000 description 3
- 230000002210 biocatalytic effect Effects 0.000 description 3
- 230000001851 biosynthetic effect Effects 0.000 description 3
- 239000013613 expression plasmid Substances 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 239000000376 reactant Substances 0.000 description 3
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 3
- 210000003705 ribosome Anatomy 0.000 description 3
- 238000010561 standard procedure Methods 0.000 description 3
- 230000014616 translation Effects 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241001485655 Corynebacterium glutamicum ATCC 13032 Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 108010054278 Lac Repressors Proteins 0.000 description 2
- 229920003189 Nylon 4,6 Polymers 0.000 description 2
- 108050007429 Ornithine decarboxylase SpeF Proteins 0.000 description 2
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000002074 deregulated effect Effects 0.000 description 2
- 150000004985 diamines Chemical class 0.000 description 2
- JBKVHLHDHHXQEQ-UHFFFAOYSA-N epsilon-caprolactam Chemical compound O=C1CCCCCN1 JBKVHLHDHHXQEQ-UHFFFAOYSA-N 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 108020001507 fusion proteins Proteins 0.000 description 2
- 102000037865 fusion proteins Human genes 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- LELOWRISYMNNSU-UHFFFAOYSA-N hydrogen cyanide Chemical compound N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical compound O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 2
- 238000011191 terminal modification Methods 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 101100275473 Caenorhabditis elegans ctc-3 gene Proteins 0.000 description 1
- 101710170109 Constitutive ornithine decarboxylase Proteins 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010077448 Diamine N-acetyltransferase Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108030000852 Glutamate N-acetyltransferases Proteins 0.000 description 1
- 102000008214 Glutamate decarboxylase Human genes 0.000 description 1
- 108091022930 Glutamate decarboxylase Proteins 0.000 description 1
- 108010093096 Immobilized Enzymes Proteins 0.000 description 1
- 235000002262 Lycopersicon Nutrition 0.000 description 1
- 241000227653 Lycopersicon Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000080590 Niso Species 0.000 description 1
- 229920002292 Nylon 6 Polymers 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 108010019653 Pwo polymerase Proteins 0.000 description 1
- 241000831652 Salinivibrio sharmensis Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 102220580025 Stromal interaction molecule 1_H72Q_mutation Human genes 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 102000005421 acetyltransferase Human genes 0.000 description 1
- 108020002494 acetyltransferase Proteins 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 238000012271 agricultural production Methods 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000000911 decarboxylating effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 229920006351 engineering plastic Polymers 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- 239000003966 growth inhibitor Substances 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000000126 in silico method Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052745 lead Inorganic materials 0.000 description 1
- 239000010871 livestock manure Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 238000006068 polycondensation reaction Methods 0.000 description 1
- 230000001915 proofreading effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 102220004442 rs121918685 Human genes 0.000 description 1
- 102220279338 rs1554888142 Human genes 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229940063675 spermine Drugs 0.000 description 1
- 238000012421 spiking Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000006276 transfer reaction Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/001—Amines; Imines
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04077046 | 2004-07-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200700104B true ZA200700104B (en) | 2008-05-28 |
Family
ID=34928370
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200700104A ZA200700104B (en) | 2004-07-15 | 2007-01-03 | Biochemical synthesis of 1,4-butanediamine |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8497098B2 (es) |
| EP (2) | EP2949755B1 (es) |
| JP (1) | JP4836948B2 (es) |
| CN (1) | CN101010433B (es) |
| AU (1) | AU2005261861B2 (es) |
| BR (1) | BRPI0513343B1 (es) |
| CA (1) | CA2571528C (es) |
| DK (1) | DK1784496T3 (es) |
| EA (1) | EA010179B1 (es) |
| ES (1) | ES2581244T3 (es) |
| IN (1) | IN2007DE00479A (es) |
| MX (1) | MX2007000566A (es) |
| MY (1) | MY152156A (es) |
| NZ (1) | NZ552631A (es) |
| TW (1) | TWI346139B (es) |
| UA (1) | UA90479C2 (es) |
| WO (1) | WO2006005603A1 (es) |
| ZA (1) | ZA200700104B (es) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2049675A1 (de) | 2006-08-01 | 2009-04-22 | Basf Se | Verfahren zur herstellung von pentamethylen-1,5-diisocyanat |
| CN101063144B (zh) * | 2007-05-10 | 2010-09-15 | 南京农业大学 | 乳酸菌谷氨酸脱羧酶基因的克隆、表达及应用 |
| KR101621256B1 (ko) | 2008-03-12 | 2016-05-16 | 도레이 카부시키가이샤 | 디아민 및 폴리아미드의 제조 방법 |
| WO2009125924A2 (ko) | 2008-04-10 | 2009-10-15 | 한국과학기술원 | 퓨트레신 고생성능을 가지는 변이 미생물 및 이를 이용한 퓨트레신의 제조방법 |
| FR2933414B1 (fr) * | 2008-07-07 | 2010-08-13 | Arkema France | Polyamide, composition comprenant un tel polyamide et leurs utilisations |
| JP5776907B2 (ja) * | 2009-07-24 | 2015-09-09 | ディーエスエム アイピー アセッツ ビー．ブイ． | Ｎ−アシル保護またはｎ−グアニジル保護１，４−ブタンジアミン前駆体を介する１，４−ブタンジアミンの調製方法 |
| CA2777459A1 (en) * | 2009-10-13 | 2011-04-21 | Genomatica, Inc. | Microorganisms for the production of 1,4-butanediol, 4-hydroxybutanal, 4-hydroxybutyryl-coa, putrescine and related compounds, and methods related thereto |
| KR101174267B1 (ko) * | 2010-01-06 | 2012-08-14 | 씨제이제일제당 (주) | Ｌ-오르니틴 또는 ｌ-아르기닌 생산 변이주 및 이의 제조방법 |
| KR101348461B1 (ko) | 2010-12-08 | 2014-01-08 | 씨제이제일제당 (주) | 퓨트레신을 생산하는 미생물 및 이를 이용하여 퓨트레신을 생산하는 방법 |
| KR101286158B1 (ko) * | 2011-08-24 | 2013-07-15 | 씨제이제일제당 (주) | 발효액에서 1,4-디아미노부탄의 분리 및 정제하는 방법 |
| CN104066835B (zh) * | 2012-01-11 | 2016-08-24 | Cj第一制糖株式会社 | 提高腐胺生产能力的重组微生物以及利用其制备腐胺的方法 |
| IN2014MN01621A (es) * | 2012-01-20 | 2015-07-03 | Cj Cheiljedang Corp | |
| KR20140052189A (ko) * | 2012-10-22 | 2014-05-07 | 씨제이제일제당 (주) | 1,4-디아미노부탄의 정제방법, 상기 방법으로 정제된 1,4-디아미노부탄 및 이로부터 제조되는 폴리아미드 |
| KR101607741B1 (ko) | 2013-03-20 | 2016-03-31 | 씨제이제일제당 (주) | 퓨트레신 생산 재조합 미생물 및 이를 이용한 퓨트레신 생산방법 |
| KR101835164B1 (ko) | 2013-07-17 | 2018-03-06 | 씨제이제일제당 (주) | 향상된 퓨트레신 생산능을 가지는 변이된 오르니틴 디카복실레이즈 단백질 및 이의 용도 |
| CN103951504A (zh) * | 2014-04-21 | 2014-07-30 | 扬州市嘉康菇业发展有限公司 | 一种促进金针菇菌丝体快速生长的培养基的制备方法 |
| CN106687579B (zh) | 2014-04-25 | 2020-10-27 | Cj第一制糖株式会社 | 产生二胺的微生物和使用该微生物产生二胺的方法 |
| US10640797B2 (en) | 2014-04-25 | 2020-05-05 | Cj Cheiljedang Corporation | Microorganisms for producing diamine and process for producing diamine using them |
| EP3135759B1 (en) | 2014-04-25 | 2018-11-21 | Cj Cheiljedang Corporation | Putrescine-producing variant strain and putrescine production method using same |
| JP2017158434A (ja) * | 2014-07-22 | 2017-09-14 | 協同乳業株式会社 | バクテリア混合培養によるプトレッシン製造方法 |
| KR101813759B1 (ko) | 2015-06-24 | 2018-01-02 | 씨제이제일제당 (주) | 퓨트레신 또는 오르니틴 생산 미생물 및 이를 이용한 퓨트레신 또는 오르니틴 생산방법 |
| KR101735935B1 (ko) | 2015-07-20 | 2017-05-16 | 씨제이제일제당 (주) | 퓨트레신 또는 오르니틴 생산 미생물 및 이를 이용한 퓨트레신 또는 오르니틴 생산방법 |
| KR102011394B1 (ko) | 2017-07-19 | 2019-10-22 | 씨제이제일제당 주식회사 | 퓨트레신을 생산하는 미생물 및 이를 이용한 퓨트레신 생산방법 |
| EP3808848A1 (en) | 2019-10-14 | 2021-04-21 | Eberhard Karls Universität Tübingen | Regulatory element of an arginine decarboxylase gene and methods and uses thereof |
| KR102246288B1 (ko) | 2020-08-13 | 2021-04-29 | 씨제이제일제당 주식회사 | 퓨트레신 생산 미생물 및 이를 이용한 퓨트레신 생산방법 |
| CN113061562B (zh) * | 2021-03-22 | 2022-09-27 | 江南大学 | 一种利用钝齿棒杆菌发酵生产1,4-丁二胺的方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2130948A (en) | 1937-04-09 | 1938-09-20 | Du Pont | Synthetic fiber |
| ES2088826B1 (es) * | 1995-02-10 | 1997-06-01 | Taguidell Sociedad Limitada | Procedimiento de obtencion de las diaminas putrescina y cadaverina a partir de productos naturales tratados, su uso como aditivo en abonos, y abono correspondiente. |
| AU6464100A (en) * | 1999-08-10 | 2001-03-05 | John Innes Centre | Polyamine accumulation in plants |
| JP2002345496A (ja) * | 2001-05-25 | 2002-12-03 | Ajinomoto Co Inc | アグマチンの製造方法およびアルギニン脱炭酸酵素の製造方法 |
-
2005
- 2005-07-11 NZ NZ552631A patent/NZ552631A/en unknown
- 2005-07-11 EP EP15175520.4A patent/EP2949755B1/en active Active
- 2005-07-11 WO PCT/EP2005/007606 patent/WO2006005603A1/en active Application Filing
- 2005-07-11 AU AU2005261861A patent/AU2005261861B2/en not_active Ceased
- 2005-07-11 EA EA200700329A patent/EA010179B1/ru not_active IP Right Cessation
- 2005-07-11 DK DK05767851.8T patent/DK1784496T3/en active
- 2005-07-11 JP JP2007520744A patent/JP4836948B2/ja active Active
- 2005-07-11 ES ES05767851.8T patent/ES2581244T3/es active Active
- 2005-07-11 MX MX2007000566A patent/MX2007000566A/es active IP Right Grant
- 2005-07-11 UA UAA200701584A patent/UA90479C2/ru unknown
- 2005-07-11 EP EP05767851.8A patent/EP1784496B1/en active Active
- 2005-07-11 US US11/632,458 patent/US8497098B2/en active Active
- 2005-07-11 BR BRPI0513343-2A patent/BRPI0513343B1/pt active IP Right Grant
- 2005-07-11 CN CN2005800236901A patent/CN101010433B/zh active Active
- 2005-07-11 CA CA2571528A patent/CA2571528C/en not_active Expired - Fee Related
- 2005-07-15 TW TW094124157A patent/TWI346139B/zh active
- 2005-07-15 MY MYPI20053244 patent/MY152156A/en unknown
-
2007
- 2007-01-03 ZA ZA200700104A patent/ZA200700104B/en unknown
- 2007-01-17 IN IN479DE2007 patent/IN2007DE00479A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MY152156A (en) | 2014-08-15 |
| CA2571528A1 (en) | 2006-01-19 |
| EA200700329A1 (ru) | 2007-08-31 |
| EP2949755A1 (en) | 2015-12-02 |
| CN101010433A (zh) | 2007-08-01 |
| JP2008505651A (ja) | 2008-02-28 |
| BRPI0513343B1 (pt) | 2020-11-03 |
| BRPI0513343A (pt) | 2008-05-06 |
| CN101010433B (zh) | 2012-03-07 |
| US20090011478A1 (en) | 2009-01-08 |
| EA010179B1 (ru) | 2008-06-30 |
| TW200605869A (en) | 2006-02-16 |
| CA2571528C (en) | 2016-02-16 |
| NZ552631A (en) | 2009-09-25 |
| EP2949755B1 (en) | 2018-03-28 |
| AU2005261861B2 (en) | 2010-08-26 |
| AU2005261861A1 (en) | 2006-01-19 |
| WO2006005603A1 (en) | 2006-01-19 |
| ES2581244T3 (es) | 2016-09-02 |
| UA90479C2 (en) | 2010-05-11 |
| JP4836948B2 (ja) | 2011-12-14 |
| US8497098B2 (en) | 2013-07-30 |
| MX2007000566A (es) | 2007-04-02 |
| EP1784496B1 (en) | 2016-04-06 |
| DK1784496T3 (en) | 2016-07-25 |
| EP1784496A1 (en) | 2007-05-16 |
| TWI346139B (en) | 2011-08-01 |
| IN2007DE00479A (es) | 2007-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2005261861B2 (en) | Biochemical synthesis of 1,4-butanediamine | |
| EP2236613B1 (en) | Biochemical synthesis of 1,4-butanediamine | |
| Jorge et al. | A new metabolic route for the production of gamma-aminobutyric acid by Corynebacterium glutamicum from glucose | |
| TW201002824A (en) | Adipate (ester or thioester) synthesis | |
| TW201127961A (en) | Preparation of a compound comprising an amine group from an alpha-keto acid | |
| JP2013530713A (ja) | （ｒ）−選択的アミノ化 | |
| KR101292838B1 (ko) | 재조합 대장균을 이용한 ５―아미노발레르산의 제조 방법 | |
| BRPI0513362B1 (pt) | Process for obtaining 1,4-butanodiamine in a fermentation process |